Adjuvant Intraarterial Lipiodol or <sup>131</sup>I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial - Concepedia

Concepedia

Publication | Open Access

Adjuvant Intraarterial Lipiodol or <sup>131</sup>I-Lipiodol After Curative Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial

DOI Full Paper Access

21

Citations

15

References

2014

Year

Jérôme Dumortier, Évelyne Decullier, Marie‐Noëlle Hilleret, Sylvie Bin-Dorel, Pierre‐Jean Valette, Olivier Boillot, Christian Partensky, Christian Létoublon, Christian Ducerf, Vincent Leroy,

Journal of Nuclear Medicine

Abstract

After curative treatment of patients with HCC, one 2,200-MBq dose of intraarterial (131)I-lipiodol significantly decreased the rate of intrahepatic recurrence but failed to improve overall or specific survival.

References

	Year	Citations

Page 1